These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

253 related items for PubMed ID: 1586979

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Acquisition of platinum drug resistance and platinum cross resistance patterns in a panel of human ovarian carcinoma xenografts.
    Jones M, Siracky J, Kelland LR, Harrap KR.
    Br J Cancer; 1993 Jan; 67(1):24-9. PubMed ID: 8427780
    [Abstract] [Full Text] [Related]

  • 3. Preclinical antitumor evaluation of bis-acetato-ammine-dichloro-cyclohexylamine platinum(IV): an orally active platinum drug.
    Kelland LR, Abel G, McKeage MJ, Jones M, Goddard PM, Valenti M, Murrer BA, Harrap KR.
    Cancer Res; 1993 Jun 01; 53(11):2581-6. PubMed ID: 8388318
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. The establishment, characterization and calibration of human ovarian carcinoma xenografts for the evaluation of novel platinum anticancer drugs.
    Harrap KR, Jones M, Siracky J, Pollard LA, Kelland LR.
    Ann Oncol; 1990 Jun 01; 1(1):65-76. PubMed ID: 2078487
    [Abstract] [Full Text] [Related]

  • 6. Biological properties of ten human ovarian carcinoma cell lines: calibration in vitro against four platinum complexes.
    Hills CA, Kelland LR, Abel G, Siracky J, Wilson AP, Harrap KR.
    Br J Cancer; 1989 Apr 01; 59(4):527-34. PubMed ID: 2653399
    [Abstract] [Full Text] [Related]

  • 7. Preclinical activity of a new platinum analogue, lobaplatin, in cisplatin-sensitive and -resistant human testicular, ovarian, and gastric carcinoma cell lines.
    Harstrick A, Bokemeyer C, Scharnofkse M, Hapke G, Reile D, Schmoll HJ.
    Cancer Chemother Pharmacol; 1993 Apr 01; 33(1):43-7. PubMed ID: 8269588
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Synthesis and in vitro and in vivo antitumor activity of a series of trans platinum antitumor complexes.
    Kelland LR, Barnard CF, Evans IG, Murrer BA, Theobald BR, Wyer SB, Goddard PM, Jones M, Valenti M, Bryant A.
    J Med Chem; 1995 Aug 04; 38(16):3016-24. PubMed ID: 7636864
    [Abstract] [Full Text] [Related]

  • 10. Comparative cytotoxicity of CI-973, cisplatin, carboplatin and tetraplatin in human ovarian carcinoma cell lines.
    Perez RP, O'Dwyer PJ, Handel LM, Ozols RF, Hamilton TC.
    Int J Cancer; 1991 May 10; 48(2):265-9. PubMed ID: 2019469
    [Abstract] [Full Text] [Related]

  • 11. Comparison of cellular accumulation and cytotoxicity of cisplatin with that of tetraplatin and amminedibutyratodichloro(cyclohexylamine)platinum(IV) (JM221) in human ovarian carcinoma cell lines.
    Mistry P, Kelland LR, Loh SY, Abel G, Murrer BA, Harrap KR.
    Cancer Res; 1992 Nov 15; 52(22):6188-93. PubMed ID: 1423261
    [Abstract] [Full Text] [Related]

  • 12. DNA-binding properties of novel cis- and trans platinum-based anticancer agents in 2 human ovarian carcinoma cell lines.
    Mellish KJ, Barnard CF, Murrer BA, Kelland LR.
    Int J Cancer; 1995 Sep 15; 62(6):717-23. PubMed ID: 7558420
    [Abstract] [Full Text] [Related]

  • 13. Novel trans platinum complexes: comparative in vitro and in vivo activity against platinum-sensitive and resistant murine tumours.
    Goddard PM, Orr RM, Valenti MR, Barnard CF, Murrer BA, Kelland LR, Harrap KR.
    Anticancer Res; 1996 Sep 15; 16(1):33-8. PubMed ID: 8615631
    [Abstract] [Full Text] [Related]

  • 14. The relationships between glutathione, glutathione-S-transferase and cytotoxicity of platinum drugs and melphalan in eight human ovarian carcinoma cell lines.
    Mistry P, Kelland LR, Abel G, Sidhar S, Harrap KR.
    Br J Cancer; 1991 Aug 15; 64(2):215-20. PubMed ID: 1892748
    [Abstract] [Full Text] [Related]

  • 15. Selective potentiation of platinum drug cytotoxicity in cisplatin-sensitive and -resistant human ovarian carcinoma cell lines by amphotericin B.
    Sharp SY, Mistry P, Valenti MR, Bryant AP, Kelland LR.
    Cancer Chemother Pharmacol; 1994 Aug 15; 35(2):137-43. PubMed ID: 7987990
    [Abstract] [Full Text] [Related]

  • 16. Evaluation of novel ammine/amine platinum (IV) dicarboxylates in L1210 murine leukaemia cells sensitive and resistant to cisplatin, tetraplatin or carboplatin.
    Orr RM, O'Neill CF, Nicolson MC, Barnard CF, Murrer BA, Giandomenico CM, Vollano JF, Harrap KR.
    Br J Cancer; 1994 Sep 15; 70(3):415-20. PubMed ID: 8080724
    [Abstract] [Full Text] [Related]

  • 17. Cellular pharmacology of cis and trans pairs of platinum complexes in cisplatin-sensitive and -resistant human ovarian carcinoma cells.
    O'Neill CF, Hunakova L, Kelland LR.
    Chem Biol Interact; 1999 Nov 15; 123(1):11-29. PubMed ID: 10597899
    [Abstract] [Full Text] [Related]

  • 18. In vitro phase II comparison of the cytotoxicity of a novel platinum analog, nedaplatin (254-S), with that of cisplatin and carboplatin against fresh, human ovarian cancers.
    Alberts DS, Fanta PT, Running KL, Adair LP, Garcia DJ, Liu-Stevens R, Salmon SE.
    Cancer Chemother Pharmacol; 1997 Nov 15; 39(6):493-7. PubMed ID: 9118460
    [Abstract] [Full Text] [Related]

  • 19. Oxaliplatin, tetraplatin, cisplatin, and carboplatin: spectrum of activity in drug-resistant cell lines and in the cell lines of the National Cancer Institute's Anticancer Drug Screen panel.
    Rixe O, Ortuzar W, Alvarez M, Parker R, Reed E, Paull K, Fojo T.
    Biochem Pharmacol; 1996 Dec 24; 52(12):1855-65. PubMed ID: 8951344
    [Abstract] [Full Text] [Related]

  • 20. cis-Amminedichloro(2-methylpyridine) platinum(II) (AMD473), a novel sterically hindered platinum complex: in vivo activity, toxicology, and pharmacokinetics in mice.
    Raynaud FI, Boxall FE, Goddard PM, Valenti M, Jones M, Murrer BA, Abrams M, Kelland LR.
    Clin Cancer Res; 1997 Nov 24; 3(11):2063-74. PubMed ID: 9815598
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.